The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat

Thrombosis and Haemostasis

Volumn 76, Issue 1, 1996, Pages 94-98

  Herbert, J M ^a   Bernat, A ^a   Samama, M ^b   Maffrand, J P ^a  

^a SANOFI   (France)

^b Laboratoire Central d'Hematologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; PROSTAGLANDIN SYNTHASE; TICLOPIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLEEDING TIME; BLOOD VESSEL INJURY; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

EID: 0030055523     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650529     Document Type: Article

References (28)

1. McTavish D, Faulds D, Goa KL. Ticlopidine: an updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 1990; 40 (2): 238-59.
2. Féliste R, Delebassée D, Simon MF, Chap H, Defreyn G, Vallée E, Douste-Blazy L, Maffrand JP. Broad spectrum antiplatelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thromb Res 1987; 48: 403-15.
3. Gent M, Easton JD, Hachinski VC, Panak E, Sicurella J, Blakely JA, Ellis DJ, Harbinson JW, Roberts RS, Turpie AGO, the CATS Group. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989; 1: 1215-20.
4. Mass WK, Easton JD, Harold P, Adams Jr, Pryse-Phillips W, Molonu BA, Anderson S, Kamm B, for the Ticlopidine Aspirin Stroke Study. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501-7.
5. Janzon L, Bergqvist D, Boberg J, Boberg M, Eriksson I, Lindgarde F, Persson G. Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study. Scand J Int Med 1990; 227: 301-8.
6. Van Belle E, McFadden EP, Lablanche JM, Bauters C, Hamon M, Bertrand ME. Two-pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: an alternative therapeutic strategy after bailout stent implantation. Coronary Artery Disease 1995; 6: 341-5.
7. Jordan C, Carvalho H, Fajadet J, Cassagneau B, Robert G, Marco J. Reduction of subacute thrombosis rate after coronary stenting using a new anticoagulant protocol. Circulation 1994; 90 (4): I125. (Abst 668).
8. Morice MC, Zemour G, Benveniste E, Biron Y, Bourdonnec C, Faivre R, Fajadet J, Gaspard P, Glatt B, Joly P, Labrunie P, Lienhart Y, Marco J, Petiteau PY, Royer T, Valeix B. Intracoronary stenting without coumadin: one month results of a French multicenter study. Catheterization & Cardiovasc Diagn 1995; 35: 1-7.
9. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168:178-95.
10. Umetzu T, Sanai K. Effect of 1-Methyl-2Mercapto-5-(3-Pyridyl)-Imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats. Thromb Haemost 1978; 39: 74-83.
11. Kumada T, Ishihara M, Ogawa H, Abiko Y. Experimental model of venous thrombosis in rats and effects of some agents. Thromb Res 1980; 18: 189-203.
12. Fishman JA, Ryan GB, Karnovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest 1975; 32: 339.
13. Dejana E, Villa S, de Gaetano G. Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost 1982; 48: 108-11.
14. Maffrand JP, Bernat A, Delebassée D, Defreyn G, Cazenave JP, Gordon JL. ADP plays a key role in thrombogenesis in rats. Thromb Haemost 1988; 59 (2): 225-30.
15. Cattaneo. Antiplatelet Trialisls' Collaboration. Secondary prevention of vascular events by prolonged antiplatelet therapy. British Med J 1988; 296: 320-31.
16. 3H]-2-Methylthio ADP to rat platelets - Effect of clopidogrel and ticlopidine. J Pharmacol Exp Ther 1994; 269 (2): 772-7.
17. Cerletti C, Gambino MC, Garattini S, de Gaetano G. Biochemical selectivity of oral versus intravenous aspirin in rats. J Clin Invest 1986; 78: 323-6.
18. Shand RA, Smith JR, Wallis RB. Expression of the platelet procoagulant activity in vivo in thrombus formation in an extracorporeal shunt in the rat. Thromb Res 1984; 36: 223-32.
19. Herbert JM, Tissinier A, Defreyn G, Maffrand JP. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Atheriosclerosis and Thrombosis 1993; 13: 1171-9.
20. Tallarida RJ. Statistical analysis of drug combinations for synergism. Pain 1992; 49: 93-7.
21. Conard J, Lecrubier C, Scarabin PY, Horellou MH, Samama M, Bousser MG. Effects of long term administration of ticlopidine on platelet function and hemostatic variables. Thromb Res 1980; 20: 134.
22. Pumphrey CW, Fuster V, Dewanjee MK, Murphy KP, Vliestra RE, Kaye MP. A new in vivo model of arterial thrombosis: the effect of administration of ticlopidine and verapamil in dogs. Thromb Res 1982; 28: 663.
23. Geroulanos S, Walter P, Cogan C, Binkert M, Turina M, Senning A. Platelet inhibitors. Haemostasis 1982; 12: 155 (Abstract).
24. Clowes AW, Karnovsky MJ. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endohtelial injury in the rat. Lab Invest 1977; 36: 452.
25. Dejana R, Cazenave JP, Groves HM, Kinlough-Rathbone RL, Richardson M, Packham MA, Mustard JF. The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae. Thromb Res 1980; 17: 453-8.
26. Reece AH, Walton PL. Inhibition of intimal proliferation of rabbit aorta by ticlopidine. Thromb Haemost 1979; 42: 367.
27. Born GVR. Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view. Circulation 1985; 72: 741-6.
28. Zawilska KM, Born GVR, Beent NA. Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits, Br J Haematol 1982; 50: 317-25.